Wool-derived keratin dressings versus usual care dressings for treatment of slow healing venous leg ulceration: a randomised controlled trial (Keratin4VLU)
Andrew Jull, Angela Wadham, Chris Bullen, Varsha Parag, Carolina Weller, Jill Waters, Andrew Jull, Angela Wadham, Chris Bullen, Varsha Parag, Carolina Weller, Jill Waters
Abstract
Objective: To determine the effect of a keratin dressing for treating slow-to-heal venous leg ulcers (VLU) on VLU healing.
Design: Pragmatic parallel group randomised controlled trial.
Setting: Community-dwelling participants.
Participants: People aged 18 or more years with VLU (either present for more than 26 weeks or ulcer area larger than 5 cm2 or both).
Intervention: Wool-derived keratin dressing or usual care formulary of non-medicated dressings, on a background treatment with compression.
Primary and secondary outcome measures: Healing at 24 weeks based on blinded assessment of ulcer photographs. Other outcomes included time to complete healing, change in ulcer area to 24 weeks, change in health-related quality of life and incidence of adverse events.
Results: We screened 1068 patients with VLU and randomised 143 participants (51.1% of target recruitment), 71 to the keratin dressing group and 72 to the usual care group.The mean age was 66.1 years (SD 15.9) and 53 participants (37.1%) were women. There were no significant differences between the groups on the primary outcome (risk difference -6.4%, 95% CI -22.5% to 9.7%), change in ulcer area (-1.9 cm2, 95% CI -16.5 to 12.8 cm2), time to complete healing (HR 0.80, 95% CI 0.52 to 1.23) or the incidence of adverse events (incidence rate ratio 1.19, 95% CI 0.89 to 1.59) in the intention-to-treat analyses. However, the direction of effect on the primary outcome was reversed in a per protocol analysis specified a priori (risk difference 6.2%, 95% CI -12.4% to 24.9%).
Conclusion: The effect of adding a keratin dressing to the treatment regimen for prognostically slow-to-heal VLU remains unclear.
Trial registration number: NCT02896725.
Keywords: clinical trials; dermatology; geriatric medicine; vascular medicine; wound management.
Conflict of interest statement
Competing interests: None declared.
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Figures
References
- Morasso MI, Tomic-Canic M. Epidermal stem cells: the cradle of epidermal determination, differentiation and wound healing. Biol Cell 2005;97:173–83. 10.1042/BC20040098
- Pastar I, Stojadinovic O, Yin NC, et al. . Epithelialization in wound healing: a comprehensive review. Adv Wound Care 2014;3:445–64. 10.1089/wound.2013.0473
- Charles CA, Tomic-Canic M, Vincek V, et al. . A gene signature of nonhealing venous ulcers: potential diagnostic markers. J Am Acad Dermatol 2008;59:758–71. 10.1016/j.jaad.2008.07.018
- Tang L, Sierra JO, Kelly R, et al. . Wool-derived keratin stimulates human keratinocyte migration and types IV and VII collagen expression. Exp Dermatol 2012;21:458–60. 10.1111/j.1600-0625.2012.01505.x
- Pechter PM, Gil J, Valdes J, et al. . Keratin dressings speed epithelialization of deep partial-thickness wounds. Wound Repair Regen 2012;20:236–42. 10.1111/j.1524-475X.2012.00768.x
- Margolis DJ, Berlin JA, Strom BL. Which venous leg ulcers will heal with limb compression bandages? Am J Med 2000;109:15–19. 10.1016/S0002-9343(00)00379-X
- Dumville JC, Worthy G, Bland JM, et al. . Larval therapy for leg ulcers (Venus II): randomised controlled trial. BMJ 2009;338:b773. 10.1136/bmj.b773
- Watson JM, Kang’ombe AR, Soares MO, et al. . Venus III: a randomised controlled trial of therapeutic ultrasound in the management of venous leg ulcers. Health Technol Assess 2011;15 10.3310/hta15130
- Iglesias C, Nelson E, Cullum N, et al. . Venus I: a randomised controlled trial of two types of bandage for treating venous leg ulcers. Health Technol Assess 2004;8:1–105. 10.3310/hta8290
- Ashby RL, Gabe R, Ali S, et al. . VenUS IV (Venous leg Ulcer Study IV) - compression hosiery compared with compression bandaging in the treatment of venous leg ulcers: a randomised controlled trial, mixed-treatment comparison and decision-analytic model. Health Technol Assess 2014;18:1–294. 10.3310/hta18570
- Jull A, Wadham A, Bullen C, et al. . Low dose aspirin as adjuvant treatment for venous leg ulceration: pragmatic, randomised, double blind, placebo controlled trial (Aspirin4VLU). BMJ 2017;358:j5157 10.1136/bmj.j5157
- Jull A, Wadham A, Bullen C, et al. . Wool-derived keratin dressings versus usual care dressings for treatment of slow-healing venous leg ulceration: study protocol for a randomised controlled trial (Keratin4VLU). BMJ Open 2018;8:e020319. 10.1136/bmjopen-2017-020319
- International Wound Infection Institute Wound infection in clinical practice: wounds international, 2016.
- Stacey MC, Burnand KG, Layer GT, et al. . Measurement of the healing of venous ulcers. Aust N Z J Surg 1991;61:844–8. 10.1111/j.1445-2197.1991.tb00169.x
- Fu X, Kelly R, Marsh C, et al. . A concurrent cohort clinical study of functional keratin dressings for treatment of chronic venous leg ulcers. Symposium on advanced wound care. Denver, Colorado, 2013.
- Vivas AC, Maderal AD, Than MP, et al. . Designing clinical trials to bring wound products to market. Int Wound J 2013;10:114–5. 10.1111/j.1742-481X.2011.00907.x
- Davidson A, Jina NH, Marsh C, et al. . Do functional keratin dressings accelerate epithelialization in human partial thickness wounds? A randomized controlled trial on skin graft donor sites. Eplasty 2013;13:e45.
- Batzer AT, Marsh C, Kirsner RS. The use of keratin-based wound products on refractory wounds. Int Wound J 2016;13:110–5. 10.1111/iwj.12245
- Nelson EA, Iglesias CP, Cullum N, et al. . Randomized clinical trial of four-layer and short-stretch compression bandages for venous leg ulcers (VenUS I). Br J Surg 2004;91:1292–9. 10.1002/bjs.4754
- Jull A, Walker N, Parag V, et al. . Randomized clinical trial of honey-impregnated dressings for venous leg ulcers. Br J Surg 2008;95:175–82. 10.1002/bjs.6059
- Serena T, Robson MC, Cooper DM, et al. . Lack of reliability of clinical/visual assessment of chronic wound infection: the incidence of biopsy-proven infection in venous leg ulcers. Wounds 2006;18:197–202.
- Food and Drug Administration Guidance for industry chronic cutaneous ulcer and burn wounds — developing products for treatment. Rockville, Maryland: Food and Drug Administration, 2006.
- Jull A, Parag V, Walker N, et al. . The PREPARE pilot RCT of home-based progressive resistance exercises for venous leg ulcers. J Wound Care 2009;18:497–503. 10.12968/jowc.2009.18.12.45606
Source: PubMed